Therapeutic effect of saccharomyces boulardii combined with standard triple therapy for helicobacter pylori eradication

Chinese Journal of Gastroenterology

Volumn 17, Issue 9, 2012, Pages 555-557

  Gao, Chengcheng ^a   Xie, Rui ^a   Ma, Tianheng ^a   Wu, Shangnong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gastritis; Helicobacter pylori; Saccharomyces boulardii; Therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FUNGAL EXTRACT; RABEPRAZOLE; SACCHAROMYCES BOULARDII EXTRACT; UNCLASSIFIED DRUG; UREA C 13;

ARTICLE; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; SACCHAROMYCES BOULARDII; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

EID: 84871216183     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2012.09.009     Document Type: Article

References (11)

1. 2010, 15 (8): 483-485.
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease[J]. JAMA, 1994, 272 (1): 65-69.
3. 2011, 91 (29): 2017-2018.
4. 2007, 12 (9): 525-530.
5. 2006, 86 (38): 2679-2682.
6. 2010, 15 (2): 68-70.
7. 2006, 26 (12): 850-851.
8. 2010, 15 (1): 43-46.
9. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum A L. Helicobacter pylori and probiotics[J]. J Nutr, 2007, 137 (3 Suppl 2): 812S-813S.
10. Iakovenko E P, Grigor'ev PIa, Iakovenko A V, et al. Effects of probiotic bififormon efficacy of Helicobacter pylori infection treatment[J]. Ter Arkh, 2006, 78 (2): 21-26.
11. Sheu B S, Wu J J, Lo C Y, et al. Impact of supplement with Lactobacillus-and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication[J]. Aliment Pharmacol Ther, 2002, 16 (9): 1669-1675.